News
Fluoroquinolones linked to sudden death risk for those on hemodialysis
October 25, 2021
Most patients undergoing hemodialysis have a least one risk factor for drug-induced QT interval prolongation.
News
Even one vaccinated member can cut family’s COVID risk
October 14, 2021
Study findings may be particularly welcome in regions of the world where vaccination rates are very low, according to investigators.
News
COVID-19 mitigation measures led to shifts in typical annual respiratory virus patterns
August 11, 2021
“Clinicians should be aware of increases in some respiratory virus activity and remain vigilant for off-season increases.”
![1]()
News
Injectable monoclonal antibodies prevent COVID-19 in trial
August 6, 2021
The cocktail of casirivimab and imdevimab reduced the relative risk of infection by 72% in patients at high risk of infection.
News
Standard medical mask can protect wearer from aerosols
July 12, 2021
Although this study showed how well different masks filtered out particles, it could not assess how well different masks prevent actual infection.
News
Antimicrobial resistance threat continues during COVID-19
July 6, 2021
For some patients, the pandemic and antimicrobial resistance are intertwined.
![1]()
News
Tofacitinib shows mortality benefit in patients with COVID-19 pneumonia
June 23, 2021
The Janus kinase inhibitor tofacitinib reduces the risk of both death and respiratory failure in hospitalized adults with COVID-19 pneumonia.
![1]()
News
Pediatric bronchiolitis: Less is more
April 27, 2021
With bronchiolitis still the poster disease for low-value interventions, it’s time to retire widely used but ineffective therapies and focus on supportive care, researchers say.
News
Pediatric bronchiolitis admissions to ICU fall during COVID-19
March 29, 2021
It’s unlikely that the reduction in bronchiolitis PICU admissions was due to parents not bringing babies to the hospital or infants not getting admitted.
![1]()
News
Arthritis drugs ‘impressive’ for severe COVID but not ‘magic cure’
January 15, 2021
U.S. and U.K. experts weigh in on research that compares monoclonal antibody therapies with usual care for people critically ill with COVID-19.
